NexgenRx Inc.  

(Public, CVE:NXG)   Watch this stock  
Find more results for David C. Loucks
0.000 (0.00%)
Delayed:   3:44PM EST
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.09 - 0.84
Open     -
Vol / Avg. 0.00/3,276.00
Mkt cap 10.62M
P/E     -
Div/yield     -
EPS 0.00
Shares 58.77M
Beta 0.08
Inst. own     -
Mar 25, 2016
Q4 2015 NexgenRx Inc Earnings Release (Estimated) Add to calendar
Nov 17, 2015
Q3 2015 NexgenRx Inc Earnings Release

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -9.94% -11.33%
Operating margin -9.94% -11.33%
EBITD margin - -8.54%
Return on average assets -68.58% -46.52%
Return on average equity -298.87% -
Employees 20 -
CDP Score - -


185 the West Mall Suite 600
+1-416-6953393 (Phone)
+1-416-6951635 (Fax)

Website links


NexgenRx Inc. (NexgenRx) is a Canada-based company engaged in the sale of its administration and health benefit claims adjudication services. The Company sells its administration and health benefit claims adjudication services to organizations who manage health benefit plans on behalf of plan sponsors, such as employers and associations, among others, and to a lesser extent directly to Canadian plan sponsors who wish to provide an Administrative Services Only (ASO) health benefit plan to their plan members. The health benefit claims include drug, dental, extended health and healthcare spending account claims. The Company sells its service on a fee-per-transaction basis, in addition to per member administration fees.

Officers and directors

Thomas F. Corcoran Chairman of the Board
Ronald C. Loucks President, Chief Executive Officer, Director
Taba Merrikh Acting Chief Financial Officer
Patrick G. Crowley Director
Barry J. Reiter Director
Age: 66
Ralph Soberano Director
David A. Rosenkrantz Independent Director